00690 联康生物科技集团
按盘价 
0.064 -0.001 (-1.538%) | 2023/06 - 中期 港元() | 2022/06 港元() | 2021/06 港元() | 2020/06 港元() | 2019/06 港元() |
非流动资产
| 投资物业 | 0 | 0 | 169,000 | 9,138,000 | 9,476,000 |
| 物业、厂房、设备及其他 | 41,144,000 | 39,206,000 | 46,905,000 | 36,563,000 | 48,332,000 |
| 租賃土地 | 15,294,000 | 15,492,000 | 15,629,000 | -- | -- |
| 无形资产 | 34,124,000 | 7,379,000 | 8,444,000 | 38,252,000 | 48,071,000 |
| 联营公司及共同控制公司权益 | 0 | 0 | 0 | 0 | 0 |
| 其他非流动资产 | 21,745,000 | 0 | 0 | 16,598,000 | 18,684,000 |
| 112,307,000 | 62,077,000 | 71,147,000 | 100,551,000 | 124,563,000 |
流动资产
| 存货 | 34,997,000 | 45,179,000 | 30,825,000 | 17,284,000 | 15,319,000 |
| 现金及银行结存 | 95,833,000 | 81,933,000 | 97,230,000 | 45,157,000 | 59,712,000 |
| 其他流动资产 | 68,145,000 | 73,289,000 | 88,545,000 | 92,880,000 | 107,695,000 |
| 持作出售资产 | 0 | 0 | 0 | 0 | 0 |
| 198,975,000 | 200,401,000 | 216,600,000 | 155,321,000 | 182,726,000 |
流动负债
| 其他流动负债 | 80,413,000 | 76,613,000 | 89,045,000 | 29,359,000 | 51,180,000 |
| 持作出售资产相关负债 | 0 | 0 | 0 | 0 | 0 |
| 80,413,000 | 76,613,000 | 89,045,000 | 29,359,000 | 51,180,000 | |
| 流动资产净值 | 118,562,000 | 123,788,000 | 127,555,000 | 125,962,000 | 131,546,000 |
| 资产总额减流动负债 | 230,869,000 | 185,865,000 | 198,702,000 | 226,513,000 | 256,109,000 |
非流动负债
| 6,110,000 | 5,240,000 | 4,120,000 | 397,000 | 495,000 |
资本及储备
| 股本 | 63,648,000 | 63,648,000 | 64,060,000 | 64,258,000 | 61,950,000 |
| 储备 | 161,111,000 | 116,977,000 | 130,522,000 | 161,858,000 | 193,664,000 |
| 其他 | 0 | 0 | 0 | 0 | 0 |
| 股东资金 | 224,759,000 | 180,625,000 | 194,582,000 | 226,116,000 | 255,614,000 |
| 非控股权益 | 0 | 0 | 0 | 0 | 0 |
| 其他 | 0 | 0 | 0 | 0 | 0 |
| 224,759,000 | 180,625,000 | 194,582,000 | 226,116,000 | 255,614,000 |
承担及或然负债
| 承担 | -- | -- | -- | -- | -- |
| 或然负债 | -- | -- | -- | -- | -- |
| 备注： | 实时报价更新时间为11/06/2024 12:52 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | HKD 70,876,000 |
| 增长率 | 84.036% |
| 每股盈利/(亏损) | HKD 0.011 |
| 每股账面资产净值 ($) | HKD 0.040 |